CD47 Blockade and Rituximab in Non-Hodgkin’s Lymphoma

N Engl J Med. 2019 Jan 31;380(5):496-7. doi: 10.1056/NEJMc1816156.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Adult
  • Antibodies, Monoclonal
  • Child
  • Humans
  • Lymphoma, Non-Hodgkin*
  • Rituximab*

Substances

  • Antibodies, Monoclonal
  • Rituximab